228 related articles for article (PubMed ID: 29345403)
1. Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study.
Brieger D; Chow C; Gullick J; Hyun K; D'Souza M; Briffa T;
Intern Med J; 2018 May; 48(5):541-549. PubMed ID: 29345403
[TBL] [Abstract][Full Text] [Related]
2. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
3. Impact of medical consultation frequency on risk factors and medications 6 months after acute coronary syndrome.
Hyun K; Brieger D; Chow CK; Ilton M; Amos D; Alford K; Roberts-Thomson P; Santo K; Atkins ER; Redfern J
Public Health Res Pract; 2016 Jan; 26(1):e2611606. PubMed ID: 26863169
[TBL] [Abstract][Full Text] [Related]
4. Non-physician health workers for improving adherence to medications and healthy lifestyle following acute coronary syndrome: 24-month follow-up study.
Sharma KK; Gupta R; Mathur M; Natani V; Lodha S; Roy S; Xavier D
Indian Heart J; 2016; 68(6):832-840. PubMed ID: 27931556
[TBL] [Abstract][Full Text] [Related]
5. International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study.
Bakhai A; Ferrieres J; Iñiguez A; Schmitt C; Sartral M; Belger M; Zeymer U
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):518-25. PubMed ID: 21450649
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
[TBL] [Abstract][Full Text] [Related]
7. Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes.
Kassab Y; Hassan Y; Abd Aziz N; Ismail O; AbdulRazzaq H
Int J Clin Pharm; 2013 Apr; 35(2):275-80. PubMed ID: 23283596
[TBL] [Abstract][Full Text] [Related]
8. Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand.
Redfern J; Hyun K; Chew DP; Astley C; Chow C; Aliprandi-Costa B; Howell T; Carr B; Lintern K; Ranasinghe I; Nallaiah K; Turnbull F; Ferry C; Hammett C; Ellis CJ; French J; Brieger D; Briffa T
Heart; 2014 Aug; 100(16):1281-8. PubMed ID: 24914060
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
10. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
[TBL] [Abstract][Full Text] [Related]
11. Gender Difference in Secondary Prevention of Cardiovascular Disease and Outcomes Following the Survival of Acute Coronary Syndrome.
Hyun K; Negrone A; Redfern J; Atkins E; Chow C; Kilian J; Rajaratnam R; Brieger D
Heart Lung Circ; 2021 Jan; 30(1):121-127. PubMed ID: 32888821
[TBL] [Abstract][Full Text] [Related]
12. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
[TBL] [Abstract][Full Text] [Related]
13. The underutilisation of dual antiplatelet therapy in acute coronary syndrome.
Anastasius M; Lau JK; Hyun K; D'Souza M; Patel A; Rankin J; Walters D; Juergens C; Aliprandi-Costa B; Yan AT; Goodman SG; Chew D; Brieger D
Int J Cardiol; 2017 Aug; 240():30-36. PubMed ID: 28476519
[TBL] [Abstract][Full Text] [Related]
14. Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients.
Sun Y; Li C; Zhang L; Hu D; Zhang X; Yu T; Tao M; Wang DW; Shen X
Front Med; 2017 Mar; 11(1):53-61. PubMed ID: 28213881
[TBL] [Abstract][Full Text] [Related]
15. Improving the Prescribing Gap For Guideline Recommended Medications Post Myocardial Infarction.
Wilkins B; Hullikunte S; Simmonds M; Sasse A; Larsen P; Harding SA
Heart Lung Circ; 2019 Feb; 28(2):257-262. PubMed ID: 29523466
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of recurrent angina after acute coronary syndrome: the global registry acute coronary events from China (Sino-GRACE).
Zhao FH; Chen YD; Song XT; Pan WQ; Jin ZN; Yuan F; Li YB; Ren F; Lü SZ;
Chin Med J (Engl); 2008 Jan; 121(1):12-6. PubMed ID: 18208658
[TBL] [Abstract][Full Text] [Related]
17. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
18. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry.
Chiang FT; Shyu KG; Wu CJ; Mar GY; Hou CJ; Li AH; Wen MS; Lai WT; Lin SJ; Kuo CT; Kuo C; Li YH; Hwang JJ;
J Formos Med Assoc; 2014 Nov; 113(11):794-802. PubMed ID: 24076272
[TBL] [Abstract][Full Text] [Related]
19. High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study.
Goss F; Brachmann J; Hamm CW; Haerer W; Reifart N; Levenson B
Vasc Health Risk Manag; 2017; 13():127-137. PubMed ID: 28435280
[TBL] [Abstract][Full Text] [Related]
20. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
